The potential deal could lead to a whopping valuation of ChenMed at several billion dollars. The transaction would be one of Walmart's most significant investments in the healthcare sector.
The companies are in the initial phase of discussions, and terms have yet to be finalized, Bloomberg reported, citing insiders.
Focus On Affordable Care
Walmart's pursuit of ChenMed, an affordable care provider to underserved aging patients, is a strategic leap into senior healthcare, seizing a slice of the aging population's needs at affordable costs.
ChenMed, founded by physician Jen-Ling James Chen and run by the Chen family, operates on a value-based care model, offering to cover the cost of medical care for older people while taking a financial risk.
Apart from Walmart, Bloomberg highlighted that giants in the healthcare industry, such as UnitedHealth and CVS Health Corporation (NYSE:CVS), are adopting a similar strategy, tapping into the billions of dollars moving through private Medicare Advantage.
Walmart Lowering Wages, Saving Costs
Photo: Shutterstock
Price Action: WMT shares closed higher by 0.18% to $163.77 on Friday.
Photo: Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
